One in 10 Americans admit taking someone else’s Rx, according to an ongoing Reuters/psos online survey. About a quarter of those people used the prescription drugs to get high, according to the survey
One in 10 Americans admit taking someone else’s Rx, according to an ongoing Reuters/psos online survey. About a quarter of those people used the prescription drugs to get high, according to the survey.
While nearly 75% of those surveyed said they have never taken a prescription drug that was not prescribed to them, 3% said they’ve taken someone else’s Rx twice, and 2.8% said they have done it five or more times, 2.8% admitted doing it at least once, and 1.6% of respondents admitted doing it 3 or 4 times.
The survey reflects the growing problem of prescription drugs getting into the wrong hands. After marijuana, prescription drugs are the most commonly abused drug category in the United States.
Plus, many Americans say it is not very difficult to get someone else’s prescription drugs. About two-thirds were able to get drugs not prescribed to them from family members, 25.2% were given them by a friend, and 6.2% stole them from family members. Another 13.2% said the medication was prescribed to them but that it was medically unnecessary, old, or expired.
In another recent survey, more than a third of young people said they believe that prescription stimulant abuse is a big problem among their peers. In addition, 15% of people 10 to 18 years old said they have used stimulants and one-tenth said they have diverted medications.
Linda B. Cottler, PhD, MPH, chair of the Department of Epidemiology in the College of Public Health and Health Professions and the College of Medicine at the University of Florida, presented the findings at the recent College on Problems of Drug Dependence annual meeting.
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
March 6th 2025Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 mg dose in August 2024 for the emergency treatment of anaphylaxis in children and adults weighing at least 66 lbs.
Read More